ciguatoxin 3C: structure in first source
ID Source | ID |
---|---|
PubMed CID | 6442245 |
MeSH ID | M0440393 |
Synonym |
---|
ciguatoxin 3c |
148471-85-6 |
C20001 |
ctx 3c |
(1r,3s,4z,7r,9s,11r,13s,19r,20r,21s,23r,26s,28r,30e,33s,35r,37s,39r,41s,43r,44s,45s,46r,48s,49s,50s,51r,53s,55r,57r,59s,60s)-44,45,50,55,59-pentamethylspiro[2,8,12,18,22,27,34,38,42,47,52,58-dodecaoxadodecacyclo[31.28.0.03,28.07,26.09,23.011,21.013,19.035 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (59.09) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.26) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 22 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |